1. Home
  2. GAIN vs ALT Comparison

GAIN vs ALT Comparison

Compare GAIN & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GAIN
  • ALT
  • Stock Information
  • Founded
  • GAIN 2005
  • ALT 1997
  • Country
  • GAIN United States
  • ALT United States
  • Employees
  • GAIN N/A
  • ALT N/A
  • Industry
  • GAIN Finance: Consumer Services
  • ALT Biotechnology: Pharmaceutical Preparations
  • Sector
  • GAIN Finance
  • ALT Health Care
  • Exchange
  • GAIN Nasdaq
  • ALT Nasdaq
  • Market Cap
  • GAIN 497.3M
  • ALT 472.3M
  • IPO Year
  • GAIN 2005
  • ALT N/A
  • Fundamental
  • Price
  • GAIN $13.75
  • ALT $5.59
  • Analyst Decision
  • GAIN Hold
  • ALT Strong Buy
  • Analyst Count
  • GAIN 2
  • ALT 7
  • Target Price
  • GAIN $13.75
  • ALT $21.00
  • AVG Volume (30 Days)
  • GAIN 111.9K
  • ALT 2.1M
  • Earning Date
  • GAIN 05-13-2025
  • ALT 05-13-2025
  • Dividend Yield
  • GAIN 10.93%
  • ALT N/A
  • EPS Growth
  • GAIN N/A
  • ALT N/A
  • EPS
  • GAIN 1.92
  • ALT N/A
  • Revenue
  • GAIN $89,176,000.00
  • ALT $20,000.00
  • Revenue This Year
  • GAIN $6.75
  • ALT N/A
  • Revenue Next Year
  • GAIN $12.51
  • ALT N/A
  • P/E Ratio
  • GAIN $7.18
  • ALT N/A
  • Revenue Growth
  • GAIN 6.78
  • ALT N/A
  • 52 Week Low
  • GAIN $11.42
  • ALT $3.55
  • 52 Week High
  • GAIN $14.85
  • ALT $11.16
  • Technical
  • Relative Strength Index (RSI)
  • GAIN 52.98
  • ALT 56.67
  • Support Level
  • GAIN $13.67
  • ALT $4.95
  • Resistance Level
  • GAIN $13.98
  • ALT $6.05
  • Average True Range (ATR)
  • GAIN 0.27
  • ALT 0.37
  • MACD
  • GAIN -0.01
  • ALT 0.10
  • Stochastic Oscillator
  • GAIN 60.98
  • ALT 65.67

About GAIN Gladstone Investment Corporation Business Development Company

Gladstone Investment Corp operates as an externally managed, closed-end, non-diversified management investment company. Its objective is to invest in debt and equity securities of established private businesses operating in the U.S. and to (i) achieve and grow current income by investing in debt securities of established businesses. (ii) provide our stockholders with long-term capital appreciation in the value of our assets by investing in equity securities of established businesses. It focuses on investing in lower-middle-market private businesses.

About ALT Altimmune Inc.

Altimmune Inc is engaged in developing treatments for obesity and liver diseases. The Company's pipeline includes next-generation peptide therapeutics for obesity and non-alcoholic steatohepatitis (NASH) (for both, pemvidutide, formerly known as ALT-801), and for chronic hepatitis B (HepTcell). The Company is managed and operates as a single business focused on the research and development of treatments for various diseases and disorders, and vaccines.

Share on Social Networks: